Lamivudine and Zidovudine 150 mg/1 (Lamivudine and Zidovudine TABLET, FILM COATED) 150 mg/1

Lamivudine and Zidovudine 150 mg/1 is a combination medication used to manage certain viral infections. This oral tablet is designed to support treatment protocols as prescribed by healthcare professionals.

Strength

150 mg/1

Pack Size

100 TABLET, FILM COATED in 1 BLISTER PACK (31722-739-31)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lamivudine and Zidovudine 150 mg/1 is commonly used in the management of viral infections. This combination medication is often prescribed to help control the spread of the virus within the body. It is important to follow the guidance of a healthcare provider to determine the appropriate use of this medication.

Side Effects

Lamivudine and Zidovudine 150 mg/1 may cause various effects, including fatigue, headache, and nausea. Some individuals might experience changes in appetite or mild gastrointestinal discomfort. It is essential to monitor any adverse reactions and consult a healthcare professional if they persist or worsen.

Precautions & Warnings

When handling Lamivudine and Zidovudine 150 mg/1, it is crucial to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Lamivudine and Zidovudine 150 mg/1 may interact with other medications, including certain antiviral drugs and immune modulators. It is important to discuss all current medications with a healthcare provider to ensure safe and effective use. Alcohol consumption should be avoided as it may exacerbate side effects.

Frequently Asked Questions

Lamivudine and Zidovudine 150 mg/1 is used to manage certain viral infections as part of a treatment protocol.

This medication should be stored at room temperature, away from moisture and heat.

Common side effects may include fatigue, headache, nausea, and changes in appetite.

It is important to consult a healthcare provider before taking Lamivudine and Zidovudine 150 mg/1 with other medications to avoid potential interactions.

Alcohol consumption should be avoided as it may exacerbate side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.